| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $49,630 | 1 | 25 |
Sells | $6,267 | 3 | 75 |
| SCHIMMEL PAUL | director | 1 | $49,630 | 0 | $0 | $49,630 |
| DENYES NANCY | General Counsel | 0 | $0 | 1 | $1,091 | $-1,091 |
| Broadfoot Jill Marie | Chief Financial Officer | 0 | $0 | 1 | $1,521 | $-1,521 |
| Shukla Sanjay | President and CEO | 0 | $0 | 1 | $3,655 | $-3,655 |
aTyr Pharma, Inc., a biopharmaceutical firm established in San Diego, California, in 2005, is dedicated to the discovery and advancement of therapeutic solutions. Operating within the United States, the company's research focuses on pioneering novel immunological pathways to address various medical conditions. Its primary investigational drug, efzofitimod, functions as a selective modulator of NRP2. This compound is currently undergoing a Phase III clinical trial for pulmonary sarcoidosis. Additionally, efzofitimod is being evaluated in a Phase …
Over the last 12 months, insiders at aTyr Pharma, Inc. have bought $49,630 and sold $6,267 worth of aTyr Pharma, Inc. stock.
On average, over the past 5 years, insiders at aTyr Pharma, Inc. have bought $390,107 and sold $7,203 worth of stock each year.
Highest buying activity among insiders over the last 12 months: SCHIMMEL PAUL (director) — $49,630.
The last purchase of 100,000 shares for transaction amount of $49,630 was made by SCHIMMEL PAUL (director) on 2026‑05‑27.
| 2026-05-27 | SCHIMMEL PAUL | director | 100,000 0.1058% | $0.50 | $49,630 | +0.99% | ||
| 2026-02-04 | Sale | Shukla Sanjay | President and CEO | 3,745 0.0042% | $0.98 | $3,655 | -39.79% | |
| 2026-02-04 | Sale | Broadfoot Jill Marie | Chief Financial Officer | 1,558 0.0018% | $0.98 | $1,521 | -39.79% | |
| 2026-02-04 | Sale | DENYES NANCY | General Counsel | 1,118 0.0013% | $0.98 | $1,091 | -39.79% | |
| 2025-10-09 | SCHIMMEL PAUL | director | 317,999 0.4141% | $0.94 | $299,364 | -24.45% | ||
| 2025-10-08 | SCHIMMEL PAUL | director | 682,001 0.8473% | $0.90 | $612,437 | -27.73% | ||
| 2025-03-17 | Gross Jane A | director | 3,750 0.0208% | $4.00 | $15,000 | -73.57% | ||
| 2025-02-04 | Sale | Broadfoot Jill Marie | Chief Financial Officer | 1,254 0.0066% | $3.78 | $4,740 | -14.44% | |
| 2025-02-04 | Sale | DENYES NANCY | General Counsel | 899 0.0047% | $3.78 | $3,398 | -14.44% | |
| 2024-07-24 | SCHIMMEL PAUL | director | 52,300 0.1398% | $1.93 | $101,038 | +71.24% | ||
| 2024-07-23 | SCHIMMEL PAUL | director | 6,648 0.0167% | $1.82 | $12,075 | +76.20% | ||
| 2024-07-22 | SCHIMMEL PAUL | director | 41,052 0.0989% | $1.74 | $71,500 | +76.88% | ||
| 2024-06-05 | DENYES NANCY | General Counsel | 5,000 0.0128% | $1.86 | $9,276 | +70.33% | ||
| 2017-11-13 | Sale | EcoR1 Capital Fund Qualified, L.P. | 10 percent owner | 1,083 0.0059% | $3.95 | $4,278 | ||
| 2017-11-10 | Sale | EcoR1 Capital Fund Qualified, L.P. | 10 percent owner | 5,860 0.0324% | $4.00 | $23,445 | ||
| 2017-11-09 | Sale | EcoR1 Capital Fund Qualified, L.P. | 10 percent owner | 5,819 0.0334% | $4.15 | $24,151 | ||
| 2017-11-08 | Sale | EcoR1 Capital Fund Qualified, L.P. | 10 percent owner | 1,070 0.0064% | $4.30 | $4,601 | ||
| 2017-11-01 | EcoR1 Capital Fund Qualified, L.P. | 10 percent owner | 24,728 0.1642% | $4.80 | $118,694 | |||
| 2017-10-01 | EcoR1 Capital Fund Qualified, L.P. | 10 percent owner | 4,879 0.0341% | $5.05 | $24,639 |
| SCHIMMEL PAUL | director | 779143 31.7734% | $5.17M | 6 | 0 | +34.43% |
| DENYES NANCY | General Counsel | 33124 1.3508% | $219,612.12 | 1 | 2 | +70.33% |
| EcoR1 Capital Fund Qualified, L.P. | 10 percent owner | 3209316 130.8755% | $21.28M | 2 | 4 | |
| Gross Jane A | director | 9750 0.3976% | $64,642.50 | 1 | 0 |
$18,815,063 | 62 | -6.45% | $13.7M | |
$1,993,425 | 46 | -21.91% | $13.95M | |
$30,257,839 | 29 | -15.72% | $12M | |
$226,127 | 22 | -27.62% | $21.96M | |
$37,200,153 | 21 | -47.67% | $12.66M |
| Increased Positions | 39 | +27.66% | 6M | +9.75% |
| Decreased Positions | 61 | -43.26% | 14M | -22.66% |
| New Positions | 16 | New | 2M | New |
| Sold Out Positions | 36 | Sold Out | 7M | Sold Out |
| Total Postitions | 119 | -15.6% | 54M | -12.92% |